Why is a protective antigen protective?

One of the major challenges in vaccine development is the identification of microbial components that give rise to a protective immune response. Over the last decade, genome and proteome-based methods have proven successful in discovering new vaccine candidates for many pathogens through the selection of secreted or surface-exposed protein antigens and their screening in proper biological assays. However, these approaches still require intensive research activities to single out, among the large number of secreted and surface exposed proteins those very few which are protective. The question of which structural properties render an antigen capable of eliciting the production of functional remains most challenging. In such scientific and methodological context, the EU-funded project BacAbs was set up in 2007 with the main objective of developing a knowledge-based protocol able to discern protective from non-protective protein antigens, based on their amino acid sequences and molecular properties. The successful BacAbs multidisciplinary approach is highlighted by the recent analysis of three antigens from two diverse pathogens. Here, we describe the work and results carried out so far by the BacAbs Consortium, and discuss its relevance with regards to accelerating antigen selection processes and state-of-the-art vaccine development.

[1]  I. Margarit,et al.  Surfome Analysis as a Fast Track to Vaccine Discovery , 2009, Molecular & Cellular Proteomics.

[2]  M. Bolognesi,et al.  Group B Streptococcus Pullulanase Crystal Structures in the Context of a Novel Strategy for Vaccine Development , 2009, Journal of bacteriology.

[3]  G. Grandi,et al.  Functional Characterization of a Newly Identified Group B Streptococcus Pullulanase Eliciting Antibodies Able to Prevent Alpha-Glucans Degradation , 2008, PloS one.

[4]  Giorgio Colombo,et al.  Relationship between energy distribution and fold stability: Insights from molecular dynamics simulations of native and mutant proteins , 2008, Proteins.

[5]  Jue Chen,et al.  Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems , 2008, Microbiology and Molecular Biology Reviews.

[6]  G. Grandi,et al.  Proteomics Characterization of Outer Membrane Vesicles from the Extraintestinal Pathogenic Escherichia coli ΔtolR IHE3034 Mutant*S , 2008, Molecular & Cellular Proteomics.

[7]  O. Schneewind,et al.  Vaccine assembly from surface proteins of Staphylococcus aureus , 2006, Proceedings of the National Academy of Sciences.

[8]  G. Bensi,et al.  Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome , 2006, Nature Biotechnology.

[9]  H. Tettelin,et al.  Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen , 2005, Science.

[10]  G. Grandi,et al.  Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings. , 2005, Vaccine.

[11]  Rino Rappuoli,et al.  Reverse Vaccinology and Genomics , 2003, Science.

[12]  N. Ariel,et al.  Search for Potential Vaccine Candidate Open Reading Frames in the Bacillus anthracis Virulence Plasmid pXO1: In Silico and In Vitro Screening , 2002, Infection and Immunity.

[13]  R. Nogarotto,et al.  Genomic Approach for Analysis of Surface Proteins in Chlamydia pneumoniae , 2002, Infection and Immunity.

[14]  R. Rappuoli,et al.  Reverse vaccinology: a genome-based approach for vaccine development , 2002, Expert opinion on biological therapy.

[15]  J. Mattick,et al.  Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. , 2001, Vaccine.

[16]  B. Guy,et al.  Formulations of single or multiple H. pylori antigens with DC Chol adjuvant induce protection by the systemic route in mice. Optimal prophylactic combinations are different from therapeutic ones. , 2001, FEMS immunology and medical microbiology.

[17]  Theresa M. Wizemann,et al.  Use of a Whole Genome Approach To Identify Vaccine Molecules Affording Protection against Streptococcus pneumoniae Infection , 2001, Infection and Immunity.

[18]  J. Venter,et al.  Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. , 2000, Science.

[19]  K. Nishikawa,et al.  Domain dislocation: a change of core structure in periplasmic binding proteins in their evolutionary history. , 1999, Journal of molecular biology.

[20]  S. Johnston,et al.  Protection against mycoplasma infection using expression-library immunization , 1995, Nature.

[21]  G. Macfarlane,et al.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood. , 1987, Gut.

[22]  A. Levine,et al.  H2 excretion after ingestion of complex carbohydrates. , 1987, Gastroenterology.

[23]  W. Boos,et al.  Reconstitution of maltose transport in malB mutants of Escherichia coli through calcium-induced disruptions of the outer membrane , 1981, Journal of bacteriology.